Back to search

Article

Large-scale genetic analysis of age-related macular degeneration (AMD) drug targets highlights precision therapy opportunities for patients with high polygenic risk

2025-12-29

Abstract excerpt

<h4>Background</h4> In the past two decades, genetic studies have elucidated the contributions of key biological pathways to the pathogenesis of age-related macular degeneration (AMD), including complement activation, lipoprotein metabolism, angiogenesis, and extracellular matrix maintenance. Of these pathways, complement in particular has been observed to dominate the genetic architecture of AMD. Yet, clinical t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
35174d95-56d4-5085-baf8-c4896cae30f5
DOI
10.64898/2025.12.26.25343053
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Large-scale genetic analysis of age-related macular degeneration (AMD) drug targets highlights precision therapy opportunities for patients with high polygenic riskDOI 10.64898/2025.12.26.25343053
Select a neighboring publication to make it the new centre.